Lasergene Genomics Suite

THIS IS A NOTICE OF INTENT TO AWARD A SOLE-SOURCE CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE PROPOSALS.

The United States Army Medical Research Acquisition Activity (USAMRAA) in support of the U.S. Army Medical Research Institute of Infectious Disease (USAMRIID) intends to negotiate on a sole source basis, IAW FAR 13.106-1(b)(1)(i), with DNASTAR INC. 3801 Regent St. Suite G, Madison, WI 53705 as the only responsible source that can provide Lasergene Genomics Suite Annual Software License Renewal and Maintenance. This acquisition is being conducted under FAR Part 12 Acquisition of Commercial Items. Provisions and clauses in effect through Federal Acquisition Circular 2005-83 are incorporated.

U.S. Army Medical Research Institute of Infectious Disease (USAMRIID) intends to procure a firm-fixed-price requirement for license and maintenance for the following Software: (1) Lasergene Genomics Suite. The POP will be one 12-month base period and four 12-month option periods.  The software performs next generation sequencing assembly and analysis, clinical research, and traditional sequence analysis.

DNASTAR INC. is the sole developer, manufacturer, and distributor of Lasergene Genomics Suite. DNASTAR owns proprietary rights to the software at this time, and has no authorized resellers. DNASTAR Lasergene Genomics Suite is the only comprehensive software application package that meets USAMRIID’s sequencing assembly and analysis needs and also meets Army software compliance regulations. Since this is a license and maintenance renewal, USAMRIID must use the same name brand, and at this time there is only one company capable of providing this maintenance and renewal. As a result DNASTAR INC. is the only contractor that can provide the required Lasergene Genomics Suite Annual Software License and Maintenance.

The intended procurement will be classified under North American Industry Classification System (NAICS) 511210, Software Publishers with a Small Business Size Standard of $41,500,000. This notice of intent is not a request for competitive proposals and no solicitation document will be posted for this requirement. However, parties interested in responding to this notice shall submit technical data, including cost, sufficient to determine capability in providing the same product. All capability statements received by closing of this notification of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.

Based on the above information, the only technically acceptable Lasergene Genomics Suite Annual Software License Renewal and Maintenance are provided by DNASTAR INC. 3801 Regent St. Suite G, Madison, WI 53705. Submit email capabilities statements (using PDF, MS Word, Excel attachments) to Ireneusz Jozwiak at ireneusz.a.jozwiak.civ@mail.mil. Statements are due no later than 10:00 A.M. Eastern Daylight Time (EDT) on 20 August 2020. No phone calls accepted.